Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Adult-to-Adult Living Donor Transplant Cohort Study
A2ALL: Adult-to-Adult Living Transplant Cohort Study
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University/Medical College of Virginia
mi
from
Richmond, VA
Adult-to-Adult Living Donor Transplant Cohort Study
A2ALL: Adult-to-Adult Living Transplant Cohort Study
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University/Medical College of Virginia
mi
from
Richmond, VA
Click here to add this to my saved trials
Adult-to-Adult Living Donor Transplant Cohort Study
A2ALL: Adult-to-Adult Living Transplant Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of Toronto
mi
from
Toronto,
Adult-to-Adult Living Donor Transplant Cohort Study
A2ALL: Adult-to-Adult Living Transplant Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of Toronto
mi
from
Toronto,
Click here to add this to my saved trials
Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatome
Prospective Evaluation of the Clinical Utility of Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatomy
Status: Enrolling
Updated:  12/31/1969
Shands at the University of Florida
mi
from
Gainesville, FL
Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatome
Prospective Evaluation of the Clinical Utility of Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatomy
Status: Enrolling
Updated: 12/31/1969
Shands at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Transplantation Clinic
mi
from
Cleveland, OH
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Transplantation Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Status: Enrolling
Updated:  12/31/1969
Baylor University Medical Center
mi
from
Dallas, TX
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Genetic Studies of Non-Alcoholic Fatty Liver Disease
Status: Enrolling
Updated: 12/31/1969
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
Helen F. Graham Cancer Center
mi
from
Newark, DE
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
Helen F. Graham Cancer Center
mi
from
Newark, DE
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
MD Anderson Cancer Center Orlando (UF Health Cancer Center)
mi
from
Orlando, FL
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
MD Anderson Cancer Center Orlando (UF Health Cancer Center)
mi
from
Orlando, FL
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
IU Health Goshen Cancer Center
mi
from
Goshen, IN
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
IU Health Goshen Cancer Center
mi
from
Goshen, IN
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
Massachusettes General Hospital
mi
from
Boston, MA
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
Massachusettes General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
Weill Cornell -New York Presbyterian Hospital
mi
from
New York, NY
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
Weill Cornell -New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
Texas Oncology Sammons Cancer Center
mi
from
Dallas, TX
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
Texas Oncology Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
Virginia Mason Cancer Center
mi
from
Seattle, WA
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
Virginia Mason Cancer Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
Moffitt Cancer Center
mi
from
Tampa, FL
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated:  12/31/1969
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
Status: Enrolling
Updated: 12/31/1969
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Click here to add this to my saved trials
Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis
Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
University of South Florida
mi
from
Tampa, FL
Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis
Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter
In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter
Status: Enrolling
Updated:  12/31/1969
LIJ Medical Center- NSLIJ Health System
mi
from
New Hyde Park, NY
In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter
In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter
Status: Enrolling
Updated: 12/31/1969
LIJ Medical Center- NSLIJ Health System
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver Clinical Translational Research Center
mi
from
Aurora, CO
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver Clinical Translational Research Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
The Emory Clinic
mi
from
Atlanta, GA
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Winship Cancer Institute
mi
from
Atlanta, GA
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
University Hospital East
mi
from
Columbus, OH
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
University Hospital East
mi
from
Columbus, OH
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
James Cancer Hospital
mi
from
Columbus, OH
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
James Cancer Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Martha Morehouse Medical Plaza
mi
from
Columbus, OH
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Martha Morehouse Medical Plaza
mi
from
Columbus, OH
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Cancer Therapy and Research Center at UTHSCSA
mi
from
San Antonio, TX
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Cancer Therapy and Research Center at UTHSCSA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Cancer Therapy and Research Center at UTHSCSA
mi
from
San Antonio, TX
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Cancer Therapy and Research Center at UTHSCSA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Keck Hospital of USC
mi
from
Los Angeles, CA
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Keck Hospital of USC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Lac & Usc Medical Center
mi
from
Los Angeles, CA
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Lac & Usc Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
USC/Norris Comprehensive Cancer Center /Investigational Drug Services
mi
from
Los Angeles, CA
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
USC/Norris Comprehensive Cancer Center /Investigational Drug Services
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Anschutz Cancer Pavilion, Room 2224, c/o Melinda Friesleben, Pharm D
mi
from
Aurora, CO
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Anschutz Cancer Pavilion, Room 2224, c/o Melinda Friesleben, Pharm D
mi
from
Aurora, CO
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver, Anschutz Cancer Pavilion
mi
from
Aurora, CO
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver, Anschutz Cancer Pavilion
mi
from
Aurora, CO
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver, Anschutz Inpatient Pavillion
mi
from
Aurora, CO
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver, Anschutz Inpatient Pavillion
mi
from
Aurora, CO
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital Midtown Laboratory
mi
from
Atlanta, GA
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital Midtown Laboratory
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Investigational Drug Service: The Emory Clinic Bldg A
mi
from
Atlanta, GA
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Investigational Drug Service: The Emory Clinic Bldg A
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Investigational Drug Services
mi
from
Columbus, OH
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Investigational Drug Services
mi
from
Columbus, OH
Click here to add this to my saved trials
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Medical Arts and Research Center (MARC)
mi
from
San Antonio, TX
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Medical Arts and Research Center (MARC)
mi
from
San Antonio, TX
Click here to add this to my saved trials
EPI-743 for Metabolism or Mitochondrial Disorders
Therapeutic Trial of EPI -743 In Patients With Disorders of Energy Utilization or Oxidation-Reduction
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
EPI-743 for Metabolism or Mitochondrial Disorders
Therapeutic Trial of EPI -743 In Patients With Disorders of Energy Utilization or Oxidation-Reduction
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated:  12/31/1969
VA Connecticut Healthcare System
mi
from
West Haven, CT
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated: 12/31/1969
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Vitamin D, Cardiovascular Disease, and African Americans
Vitamin D and Early Markers of Cardiovascular Disease in African Americans
Status: Enrolling
Updated:  12/31/1969
Washington University
mi
from
Saint Louis, MO
Vitamin D, Cardiovascular Disease, and African Americans
Vitamin D and Early Markers of Cardiovascular Disease in African Americans
Status: Enrolling
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Fatty Acid Desaturase Activity, Fish Oil and Colorectal Cancer Prevention
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Fatty Acid Desaturase Activity, Fish Oil and Colorectal Cancer Prevention
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Physical Therapy for Women With Obstetric Trauma and Anal Incontinence
Effects of Physical Therapy on Pelvic Floor Symptoms and Quality of Life in Postpartum Women Following Severe Perineal Trauma: a Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
TriHealth, Inc
mi
from
Cincinnati, OH
Physical Therapy for Women With Obstetric Trauma and Anal Incontinence
Effects of Physical Therapy on Pelvic Floor Symptoms and Quality of Life in Postpartum Women Following Severe Perineal Trauma: a Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
TriHealth, Inc
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies
Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Science
mi
from
Winston-Salem, NC
Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies
Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Science
mi
from
Winston-Salem, NC
Click here to add this to my saved trials